Nasdaq Investment Intelligence Content Hub A Power Pharmaceuticals ETF to Consider By Tom LydonJuly 27, 2020
Equity ETF Content Hub Endo Shares Climb On Potential Treatment for Cellulite By Ian YoungSeptember 6, 2019
Innovative ETFs Content Hub Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results By Max ChenFebruary 28, 2019
Core Equity Content Hub Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook By Max ChenJanuary 23, 2019
